In the BioHarmony Drug Report Database
Propafenone
Rythmol, Rythmol Sr (propafenone) is a small molecule pharmaceutical. Propafenone was first approved as Rythmol on 1989-11-27. It is used to treat atrial fibrillation, cardiac arrhythmias, and supraventricular tachycardia in the USA. The pharmaceutical is active against beta-1 adrenergic receptor. In addition, it is known to target potassium voltage-gated channel subfamily A member 5 and beta-2 adrenergic receptor.
Trade Name
|
Rythmol, Rythmol Sr |
|---|---|
Common Name
|
propafenone |
ChEMBL ID
|
CHEMBL631 |
Indication
|
atrial fibrillation, cardiac arrhythmias, supraventricular tachycardia |
Drug Class
|
Antiarrhythmics (propafenone derivatives) |
Image (chem structure or protein)